Jupiter Neurosciences has launched a new Nugevia™ e-commerce site and begun accepting pre-orders for three inaugural nutraceutical supplements, with shipments slated for Fall 2025, according to the company.
The supplements—Nugevia™ GLO, PWR, and MND—derive from Jupiter’s patented JOTROL™ resveratrol delivery platform, which reportedly achieved a nine-fold increase in bioavailability in Phase I clinical trials. Jupiter claims the product line translates pharmaceutical-grade science into the longevity and wellness market, estimated at $8 trillion.
Each formulation is tailored to support different aspects of health: GLO for skin vitality using NovaSOL® Astaxanthin; PWR for mitochondrial function and endurance via NovaSOL® CoQ10; and MND for memory and cognitive resilience using NovaSOL® Curcumin.
Jupiter is executing a dual-path business model that pairs its CNS therapeutic development with a consumer health channel built on Nugevia™, providing a near-term revenue stream to support R&D.
Jupiter Neurosciences also named Hall of Fame golfer Annika Sörenstam and NBA legend Chris Webber as brand ambassadors, a move it claims will boost visibility and credibility for the Nugevia™ line.
